Eisai Announces Organizational Reforms; “We Won’t Allow Generics to Overwhelm AD Market”: President Naito

Haruo Naito, President and CEO, Eisai Eisai announced a plan to reform its marketing system at a press conference on March 7. The main aim of the plan is to shore up sales of the Alzheimer’s disease (AD) treatment Aricept...read more